| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 0.27▲ | 0.27▲ | 0.27▲ | 0.27▲ | 0.34▼ |
| MA10 | 0.27▲ | 0.27▲ | 0.28▼ | 0.34▼ | 0.66▼ |
| MA20 | 0.27▲ | 0.28▼ | 0.28▼ | 0.35▼ | 1.99▼ |
| MA50 | 0.27▲ | 0.28▼ | 0.31▼ | 0.85▼ | 12.00▼ |
| MA100 | 0.29▼ | 0.33▼ | 0.35▼ | 2.19▼ | 91.60▼ |
| MA200 | 0.28▼ | 0.35▼ | 0.50▼ | 9.14▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.001▲ | -0.001▼ | -0.001▼ | 0.036▲ | 1.394▲ |
| RSI | 58.282▲ | 46.559▼ | 45.738▼ | 35.414▼ | 21.221▼ |
| STOCH | 82.593▲ | 70.760 | 16.013▼ | 7.544▼ | 1.557▼ |
| WILL %R | -27.778 | -73.231 | -87.917▼ | -89.974▼ | -98.495▼ |
| CCI | 97.628 | 31.948 | -52.269 | -93.097 | -67.564 |
|
Wednesday, September 30, 2026 04:00 AM
Global Phase 2/3 trial evaluates SIL204 in combination with standard chemotherapy in patients with locally advanced pancreatic cancer Integrated regimen combines direct EUS-guided intratumoral ...
|
|
Tuesday, September 29, 2026 05:03 AM
Cayman Islands, Sept. 29, 2026 (GLOBE NEWSWIRE) -- . (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company pioneering RNA interference (RNAi) therapies for KRAS-driven ...
|
|
Monday, September 28, 2026 05:31 AM
Silexion Therapeutics Corp. (NASDAQ: SLXN) announced preclinical findings from a translational study of its lead drug candidate, SIL204, showing the compound uses naturally occurring lipoproteins in ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 30/09/26 | 0.262 | 0.2773 | 0.256 | 0.2773 | 11,126,260 |
| 29/09/26 | 0.32 | 0.40 | 0.2978 | 0.3184 | 254,082,533 |
| 28/09/26 | 0.2622 | 0.2755 | 0.2406 | 0.2484 | 34,598,951 |
| 25/09/26 | 0.24 | 0.2699 | 0.238 | 0.2603 | 1,111,106 |
| 24/09/26 | 0.269 | 0.281 | 0.25 | 0.257 | 2,305,900 |
| 23/09/26 | 0.339 | 0.382 | 0.30 | 0.315 | 7,907,000 |
| 22/09/26 | 0.4857 | 0.50 | 0.3324 | 0.3816 | 31,201,048 |
| 21/09/26 | 0.42 | 0.63 | 0.415 | 0.544 | 19,762,100 |
| 18/09/26 | 0.3953 | 0.4479 | 0.394 | 0.4379 | 25,968,004 |
| 17/09/26 | 0.366 | 0.38 | 0.35 | 0.38 | 7,926,057 |
|
|
||||
|
|
||||
|
|